Myhrvold's "System for obfuscating identity"

Note Myhrvold's published patent application 20080127350 titled System for obfuscating identity with first claim:

A method comprising:

receiving a first input associated with a first possible dataset, the first possible dataset including data representative of one or more target biological material identifiers; and
determining data representative of one or more obfuscating components for the one or more target biological material identifiers based on the first possible dataset.

Note paragraphs 2-5:

[0002]For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of U.S. patent application Ser. No. ______, entitled A SYSTEM FOR OBFUSCATING IDENTITY, naming W. Daniel Hillis, Nathan P. Myhrvold and Richa Wilson as inventors, filed Aug. 24, 2006, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date [Attorney Docket No. 1103-006-018A-000000].

[0003]For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of U.S. patent application Ser. No. ______, entitled A SYSTEM FOR OBFUSCATING IDENTITY, naming W. Daniel Hillis, Nathan P. Myhrvold and Richa Wilson as inventors, filed 24 Aug. 2006, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date [Attorney Docket No. 1103-006-018C-000000].

[0004]The United States Patent Office (USPTO) has published a notice to the effect that the USPTO's computer programs require that patent applicants reference both a serial number and indicate whether an application is a continuation or continuation-in-part. Stephen G. Kunin, Benefit of Prior-Filed Application, USPTO Official Gazette Mar. 18, 2003, available at http://www.uspto.gov/web/offices/com/sol/og/2003/week11/patbene.htm. The present applicant entity has provided above a specific reference to the application(s)from which priority is being claimed as recited by statute. Applicant entity understands that the statute is unambiguous in its specific reference language and does not require either a serial number or any characterization, such as "continuation" or "continuation-in-part," for claiming priority to U.S. patent applications. Notwithstanding the foregoing, applicant entity understands that the USPTO's computer programs have certain data entry requirements, and hence applicant entity is designating the present application as a continuation-in-part of its parent applications as set forth above, but expressly points out that such designations are not to be construed in any way as any type of commentary and/or admission as to whether or not the present application contains any new matter in addition to the matter of its parent application(s).

[0005]All subject matter of the Related Applications and of any and all parent, grandparent, great-grandparent, etc. applications of the Related Applications is incorporated herein by reference to the extent such subject matter is not inconsistent herewith.

Paragraph 29 states: The ability to mask and/or degrade biological material identifiers of individuals or groups is becoming increasingly desirable as cloning and DNA and protein-based methods of identification of individuals become commonplace. Identity theft no longer just involves credit cards, for example, but also theft of biological material, such as but not limited to, DNA and/or protein sequences that at least partially identify individuals and/or groups. Biological material identity theft could lead to non-permissive cloning of individuals and/or their tissues, or impact other privacy rights of individuals and groups relating to health care and disease, for example. Although the above-described examples are not intended to be (and should not be taken to be) in any way limiting, the present application describes systems, apparatus, kits, devices, compositions, and methods designed to address these and other related issues.

***Separately, note

published application 20080127293 [SEARETE LLC]

published application 20080126234

published application 20080123797, titled Automated nuclear power reactor for long-term operation

published application 20080114578, titled System and method related to improving an immune system

published application 20080092065, titled Third party control over virtual world characters

published application 20080088579, titled Time-lapsing mirror, first claim
A system comprising:a physical mirror;an image playback device proximate to said physical mirror; and an image registration engine operably couplable to said image playback device.

published application 20080086380 with patent attorney Tegreene as co-inventor

published application 20080086339, titled Customized visual marking for medication labeling, with first claim
A method of marking a product comprising: establishing a supplemental visual identifier for a medication or other health-related substance designated for use by a particular patient, which supplemental visual identifier includes one or more specified recognizable symbolic aspects that are intended to suggest proper administration of the medication or other health-related substance to the particular patient; and displaying the supplemental visual identifier in close association with a substance dosage.